 NEW YORK, May 29, 2021 PRNewswire -- Juan Monteverde , founder and managing partner at Monteverde Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Strongbridge Biopharma plc SBBP or the Company SBBP relating to its proposed acquisition by Xeris Pharmaceuticals, Inc. Under the terms of the agreement, SBBP shareholders will receive 0.7840 shares of Xeris per share they own. SBBP shareholders will also receive one contingent value right, worth up to 1.00 in cash per share or equivalent Xeris stock upon achievement of certain triggering events. 